4.8 Article

PCIF1 Catalyzes m6Am mRNA Methylation to Regulate Gene Expression

期刊

MOLECULAR CELL
卷 75, 期 3, 页码 620-+

出版社

CELL PRESS
DOI: 10.1016/j.molcel.2019.05.030

关键词

-

资金

  1. NIH [R01 GM117264, R35 CA210104-01, R21 AI130737-02, R01 CA118487]
  2. Boston Children's Hospital
  3. Harvard Medical School
  4. NSF [ACI-1548562, ACI-1445606]
  5. Mexican Council of Science and Technology (CONACyT) [CVU 257385]
  6. CONACyT [CVU 289937]

向作者/读者索取更多资源

mRNA modifications play important roles in regulating gene expression. One of the most abundant mRNA modifications is N6,2-O-dimethyladenosine (m6Am). Here, we demonstrate that m6Am is an evolutionarily conserved mRNA modification mediated by the Phosphorylated CTD Interacting Factor 1 (PCIF1), which catalyzes m6A methylation on 2-O-methylated adenine located at the 5' ends of mRNAs. Furthermore, PCIF1 catalyzes only 5' m6Am methylation of capped mRNAs but not internal m6A methylation in vitro and in vivo. To study the biological role of m6Am, we developed a robust methodology (m6Am-Exo-Seq) to map its transcriptome-wide distribution, which revealed no global crosstalk between m6Am and m6A under assayed conditions, suggesting that m6Am is functionally distinct from m6A. Importantly, we find that m6Am does not alter mRNA transcription or stability but negatively impacts cap-dependent translation of methylated mRNAs. Together, we identify the only human mRNA m6Am methyltransferase and demonstrate a mechanism of gene expression regulation through PCIF1-mediated m6Am mRNA methylation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据